null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the...
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores...
Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion in cash, securing access to proprietary circular RNA technology for in vivo cell engineering in autoimmune diseases and oncology....
null Novartis is reinforcing its commitment to acquiring early-stage pipeline assets and clinical-stage candidates, even as the pharmaceutical giant faces intensifying competition for late-stage drug...
Mubadala Capital has sold its minority stake in Arcadia Consumer Healthcare to funds managed by Bansk Group, marking the end of a four-year partnership that tripled the platform's revenue and...
Merck & Co. has terminated acquisition discussions with Revolution Medicines after failing to agree on price for a potential $28-32 billion deal, triggering a 20% drop in Revolution's shares and...
BioCryst Pharmaceuticals Inc. (NasdaqGS: BCRX) completed its acquisition of Astria Therapeutics Inc. (NasdaqGM: ATXS) from a group of shareholders on January 23, 2026, in a deal valued at $700...
The Clorox Company has agreed to acquire GOJO Industries, the Ohio-based manufacturer of Purell hand sanitizer and skin health products, in an all-cash transaction valued at $2.25 billion. The deal...
Former executives of a health technology company that went public through a SPAC merger have agreed to a $10 million settlement to resolve investor lawsuits alleging they triggered a bankruptcy...
GSK agreed to acquire Rapt Therapeutics for $58 per share in cash, valuing the clinical-stage biotech at $2.2 billion in equity and requiring a net cash commitment of $1.9 billion after accounting...
